The first two sessions will cover the BCG shortage, impact on clinical practice, and implications for trial design for the BCG-naïve population. The third session will focus on trial design in the BCG-unresponsive population and potential trial designs with cystectomy-free survival as a secondary endpoint
11-18-2021 09:00 AM - 11-19-2021 12:00 PM ET
Membership
JoinBenefitsRenew Your Membership
Privacy & Terms
About UsCode of Conduct